New tools can catch breast early and predict which patients are more at risk of treatment side effects. The duo of breakthroughs offer hope for the 55,000 British women diagnosed with the disease every year. One of the tools, being tested in the UK, and the , opens up the door to giving patients more personalised treatment.
Load More
Load More